Bioqore key facts
- Developer of an AI-driven biomanufacturing platform designed to optimize bioprocess development and scale biologic production.
- Notable investors include The Engine, MaC Venture Capital, Adverb Ventures, Epsilon Ventures.
- Status: Privately Held (backing).
Who backs Bioqore
4- ·Watch Bioqore: the Monday email on marks, rounds and moves
Bioqore funding rounds
No funding rounds for Bioqore are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Bioqore investors
4 investors are on record for Bioqore, including The Engine, MaC Venture Capital, Adverb Ventures and Epsilon Ventures.
About Bioqore
Developer of an AI-driven biomanufacturing platform designed to optimize bioprocess development and scale biologic production. The company offers proprietary AI models trained on real lab data, integrated with in-house experimental research, enabling biopharma researchers to reduce trial-and-error and accelerate the path from discovery to production.
- Sector
- Healthcare
- HQ
- Natick, MA, United States
- Founded
- 2024
- Employees
- 8
- Website
- bioqore.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Bioqore doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.